
Biologicals - World Health Organization (WHO)
Dec 24, 2025 · Biologicals are a class of medicines made from living cells taken from plants, animals or bacteria. These cells are use in creating many types of health care products, including vaccines. This …
Biosimilars: expanding access to essential biologic therapies
Feb 13, 2025 · Biologic medicines have transformed treatment for numerous chronic and life-threatening conditions such as cancer, auto-immune diseases, and diabetes. These therapies can offer …
Call for applications closed - 2025 Introductory course for biologics ...
Jan 23, 2025 · Course Period Proposed dates for the 2025 Introductory Course for Biologics Development and Manufacturing are: Monday, June 16, 2025 – Friday, June 27, 2025 (2 Weeks) …
Guidelines for Biologicals - World Health Organization (WHO)
Nov 19, 2004 · Guidelines for the production and control of inactivated oral cholera vaccine, Annex 3, TRS No 924 Guidelines for the production and control of inactivated oral...
Call for applications - 2026 Introductory course for Biologics ...
Jul 2, 2025 · The course includes pre-clinical & clinical trials, biologics manufacturing processes, quality control & assessment, and regulatory affairs to develop and produce vaccines and biologics, among …
Good manufacturing practices (GMP) for biological products were first published by WHO in 1992 (1). This current revision reflects subsequent developments that have taken place in science and …
Biotherapeutic products - World Health Organization (WHO)
A major industrial application of biotechnology is in the development and preparation of biological medicinal products using genetically engineered bacteria, yeast, fungi, cells or even whole animals …
Monoclonal antibodies - World Health Organization (WHO)
Jun 12, 2021 · Monoclonal antibodies (mAbs) are immunoglobulins derived from a monoclonal cell line and which have a defined specificity.
Introductory Course for Biologics Development and Manufacturing ...
Jan 15, 2024 · Low- and Middle-Income Countries (LMICs) face significant inequity in terms of access to vaccines and other biologics and are making efforts to establish biological manufacturing in their …
Introductory course for biologics development and manufacturing
Jun 27, 2025 · Why Attend? After completing the course, participants will have basic and primary knowledge about areas related to biologics manufacturing including, but not limited to, pre-clinical …